Results 191 to 200 of about 589,865 (354)
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
R. Hoppe +34 more
semanticscholar +1 more source
Summary This study provides a comprehensive assessment of haematological malignancies among children, adolescents and young adults aged 0–24 years, using data from the Global Burden of Disease 2021 across 204 countries from 1990 to 2021. We found that global incidence and prevalence remained relatively stable, with approximately 150 000 new cases and ...
Shujuan Xu +4 more
wiley +1 more source
Spatial and molecular profiling of the mononuclear phagocyte network in Classic Hodgkin lymphoma
Benjamin J. Stewart +18 more
openalex +2 more sources
Bone marrow (BM) involvement in B‐cell non‐Hodgkin lymphoma (B‐NHL) is associated with poor prognosis, as the BM microenvironment provides a protective niche that promotes therapeutic resistance. We developed a simplified, automated and high‐throughput 3D BM co‐culture model that faithfully reproduces key tumour–stroma interactions.
Alex Zadro +12 more
wiley +1 more source
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in patients with non-Hodgkin's lymphoma in the United Kingdom (UK) [PDF]
Introduction: We report a cost-effectiveness evaluation of granulocyte colony-stimulating factors (G-CSFs) for prevention of febrile neutropenia (FN) following chemotherapy for non-Hodgkin’s lymphoma (NHL) in the United Kingdom (UK).
Akehurst, R. +3 more
core
Transformation of Classical Hodgkin Lymphoma Into Non-Hodgkin Lymphoma: Three Case Reports From the West Bank. [PDF]
Abboushi MB +5 more
europepmc +1 more source
Hodgkin lymphoma: 2018 update on diagnosis, risk‐stratification, and management
S. Ansell
semanticscholar +1 more source
A visual overview of the key findings from the 35 papers included in this systematic review evaluating the use of PET volumetric parameters in children, adolescents and young adults with Hodgkin lymphoma. Summary In adults with classic Hodgkin lymphoma (cHL), metabolic tumour volume (MTV) is valuable for risk stratification.
S. Claire Gowdy +22 more
wiley +1 more source
Chemotherapy-Induced Cardiotoxicity With Frontline BV-AVD for Hodgkin Lymphoma. [PDF]
Rizzolo A, Michel C, Johnson NA.
europepmc +1 more source
miR-103 promotes the progression of non-Hodgkins lymphoma by inhibiting OTUD7B expression
Chong Wang +4 more
openalex +1 more source

